Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: A coronary care unit experience
Authors:
- 1 October 1994
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 128 (4) , 719-723
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA)JACC, 1992
- Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patencyJACC, 1992
- Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.Heart, 1992
- HeparinNew England Journal of Medicine, 1991
- Measurement of the Activated Partial Thromboplastin Time from a Capillary (fingerstick) Sample of Whole Blood: A New Method for Monitoring Heparin TherapyAmerican Journal of Clinical Pathology, 1991
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- A Novel Whole Blood Capillary Technic for Measuring the Prothrombin TimeAmerican Journal of Clinical Pathology, 1987
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Heparin and the Activated Partial Thromboplastin Time — A Difference between theIn-vitroandIn-vivoEffects and Implications for the Therapeutic RangeAmerican Journal of Clinical Pathology, 1980
- Variation among Commercial Activated Partial Thromboplastin Time Reagents in Response to HeparinAmerican Journal of Clinical Pathology, 1977